 | • レポートコード：MRC2-11QY02609 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗血栓薬のグローバル市場について調査・分析したレポートです。種類別（アピキサバン、デビガトラン、エドキサバン、フォンダパリヌクス、ヘパリン、リバーロキサバン）市場規模、用途別（一般薬局、病院薬局、オンライン小売店、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗血栓薬の競争状況、市場シェア ・世界の抗血栓薬市場：種類別市場規模 2015年-2020年（アピキサバン、デビガトラン、エドキサバン、フォンダパリヌクス、ヘパリン、リバーロキサバン） ・世界の抗血栓薬市場：種類別市場規模予測 2021年-2026年（アピキサバン、デビガトラン、エドキサバン、フォンダパリヌクス、ヘパリン、リバーロキサバン） ・世界の抗血栓薬市場：用途別市場規模 2015年-2020年（一般薬局、病院薬局、オンライン小売店、ドラッグストア） ・世界の抗血栓薬市場：用途別市場規模予測 2021年-2026年（一般薬局、病院薬局、オンライン小売店、ドラッグストア） ・北米の抗血栓薬市場分析：米国、カナダ ・ヨーロッパの抗血栓薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗血栓薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗血栓薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗血栓薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol myers squibb pharma、Abbott laboratories、Pliva、Sandoz、Pfizer、Pharmacia、Watson laboratories、Zydus pharmaceuticals usa、Bristol-Myers Squibb ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Thrombosis is may be defined as the formation of blood clot in the blood vessel or lumen part of the blood vessel. Formation of blood clots inside the blood vessel causes disruption of blood flow and it leads to cause death of cells. Deep vein thrombosis (DVT) is one type of thrombosis and it affects larger muscle of thigh. As a result, it causes pain, swelling in the leg and also it causes pulmonary embolism. Deep vein thrombosis (DVT) and pulmonary embolism collectively called as venous thromboembolism (VTE). Deep vein thrombosis is usually affects legs, sometimes it also affects chest, arm and other parts of body. If it happens in brain, lungs and heart then that could cause damage of organ.
Increasing prevalence of cardiac related and cancer diseases is one of the factor which is expected to drive the overall anti thrombotic drugs. The significant growth in a market over a forecast period is mainly attributed by increasing hereditary diseases. Globally, increasing hypertension also expected to drive the market over the forecast period. Increasing awareness about life-threatening diseases among people is a key factor and that is expected to fuel the sales of overall anti thrombotic drugs during 2016-2024. Availability of branded drugs along with generics is expected to increase the market revenue. Changing lifestyles and lack of physical activity is one of the factor which affects the growth of the market moderately during the forecast period.
Market Analysis and Insights: Global Antithrombotic Drugs Market
The global Antithrombotic Drugs market size is projected to reach US$ 20150 million by 2026, from US$ 19250 million in 2020, at a CAGR of 4.3%% during 2021-2026.
Global Antithrombotic Drugs Scope and Market Size
Antithrombotic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antithrombotic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antithrombotic Drugs market is segmented into
Apixaban
Debigatran
Edoxaban
Fondaparinux
Heparin
Rivaroxaban
Segment by Application, the Antithrombotic Drugs market is segmented into
General Pharmacies
Hospital Pharmacies
Online Retailers
Drug Stores
Regional and Country-level Analysis
The Antithrombotic Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antithrombotic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antithrombotic Drugs Market Share Analysis
Antithrombotic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antithrombotic Drugs business, the date to enter into the Antithrombotic Drugs market, Antithrombotic Drugs product introduction, recent developments, etc.
The major vendors covered:
Bristol myers squibb pharma
Abbott laboratories
Pliva
Sandoz
Pfizer
Pharmacia
Watson laboratories
Zydus pharmaceuticals usa
Bristol-Myers Squibb
1 Study Coverage
1.1 Antithrombotic Drugs Product Introduction
1.2 Market Segments
1.3 Key Antithrombotic Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antithrombotic Drugs Market Size Growth Rate by Type
1.4.2 Apixaban
1.4.3 Debigatran
1.4.4 Edoxaban
1.4.5 Fondaparinux
1.4.6 Heparin
1.4.7 Rivaroxaban
1.5 Market by Application
1.5.1 Global Antithrombotic Drugs Market Size Growth Rate by Application
1.5.2 General Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Online Retailers
1.5.5 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antithrombotic Drugs Market Size, Estimates and Forecasts
2.1.1 Global Antithrombotic Drugs Revenue 2015-2026
2.1.2 Global Antithrombotic Drugs Sales 2015-2026
2.2 Global Antithrombotic Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antithrombotic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antithrombotic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antithrombotic Drugs Competitor Landscape by Players
3.1 Antithrombotic Drugs Sales by Manufacturers
3.1.1 Antithrombotic Drugs Sales by Manufacturers (2015-2020)
3.1.2 Antithrombotic Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Antithrombotic Drugs Revenue by Manufacturers
3.2.1 Antithrombotic Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Antithrombotic Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antithrombotic Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antithrombotic Drugs Revenue in 2019
3.2.5 Global Antithrombotic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antithrombotic Drugs Price by Manufacturers
3.4 Antithrombotic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antithrombotic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antithrombotic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antithrombotic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antithrombotic Drugs Market Size by Type (2015-2020)
4.1.1 Global Antithrombotic Drugs Sales by Type (2015-2020)
4.1.2 Global Antithrombotic Drugs Revenue by Type (2015-2020)
4.1.3 Antithrombotic Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antithrombotic Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Antithrombotic Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Antithrombotic Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Antithrombotic Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antithrombotic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antithrombotic Drugs Market Size by Application (2015-2020)
5.1.1 Global Antithrombotic Drugs Sales by Application (2015-2020)
5.1.2 Global Antithrombotic Drugs Revenue by Application (2015-2020)
5.1.3 Antithrombotic Drugs Price by Application (2015-2020)
5.2 Antithrombotic Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Antithrombotic Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Antithrombotic Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Antithrombotic Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antithrombotic Drugs by Country
6.1.1 North America Antithrombotic Drugs Sales by Country
6.1.2 North America Antithrombotic Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antithrombotic Drugs Market Facts & Figures by Type
6.3 North America Antithrombotic Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Antithrombotic Drugs by Country
7.1.1 Europe Antithrombotic Drugs Sales by Country
7.1.2 Europe Antithrombotic Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antithrombotic Drugs Market Facts & Figures by Type
7.3 Europe Antithrombotic Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antithrombotic Drugs by Region
8.1.1 Asia Pacific Antithrombotic Drugs Sales by Region
8.1.2 Asia Pacific Antithrombotic Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antithrombotic Drugs Market Facts & Figures by Type
8.3 Asia Pacific Antithrombotic Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antithrombotic Drugs by Country
9.1.1 Latin America Antithrombotic Drugs Sales by Country
9.1.2 Latin America Antithrombotic Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antithrombotic Drugs Market Facts & Figures by Type
9.3 Central & South America Antithrombotic Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antithrombotic Drugs by Country
10.1.1 Middle East and Africa Antithrombotic Drugs Sales by Country
10.1.2 Middle East and Africa Antithrombotic Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antithrombotic Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Antithrombotic Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Bristol myers squibb pharma
11.1.1 Bristol myers squibb pharma Corporation Information
11.1.2 Bristol myers squibb pharma Description and Business Overview
11.1.3 Bristol myers squibb pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol myers squibb pharma Antithrombotic Drugs Products Offered
11.1.5 Bristol myers squibb pharma Related Developments
11.2 Abbott laboratories
11.2.1 Abbott laboratories Corporation Information
11.2.2 Abbott laboratories Description and Business Overview
11.2.3 Abbott laboratories Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Abbott laboratories Antithrombotic Drugs Products Offered
11.2.5 Abbott laboratories Related Developments
11.3 Pliva
11.3.1 Pliva Corporation Information
11.3.2 Pliva Description and Business Overview
11.3.3 Pliva Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pliva Antithrombotic Drugs Products Offered
11.3.5 Pliva Related Developments
11.4 Sandoz
11.4.1 Sandoz Corporation Information
11.4.2 Sandoz Description and Business Overview
11.4.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sandoz Antithrombotic Drugs Products Offered
11.4.5 Sandoz Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Antithrombotic Drugs Products Offered
11.5.5 Pfizer Related Developments
11.6 Pharmacia
11.6.1 Pharmacia Corporation Information
11.6.2 Pharmacia Description and Business Overview
11.6.3 Pharmacia Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pharmacia Antithrombotic Drugs Products Offered
11.6.5 Pharmacia Related Developments
11.7 Watson laboratories
11.7.1 Watson laboratories Corporation Information
11.7.2 Watson laboratories Description and Business Overview
11.7.3 Watson laboratories Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Watson laboratories Antithrombotic Drugs Products Offered
11.7.5 Watson laboratories Related Developments
11.8 Zydus pharmaceuticals usa
11.8.1 Zydus pharmaceuticals usa Corporation Information
11.8.2 Zydus pharmaceuticals usa Description and Business Overview
11.8.3 Zydus pharmaceuticals usa Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Zydus pharmaceuticals usa Antithrombotic Drugs Products Offered
11.8.5 Zydus pharmaceuticals usa Related Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Corporation Information
11.9.2 Bristol-Myers Squibb Description and Business Overview
11.9.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bristol-Myers Squibb Antithrombotic Drugs Products Offered
11.9.5 Bristol-Myers Squibb Related Developments
11.1 Bristol myers squibb pharma
11.1.1 Bristol myers squibb pharma Corporation Information
11.1.2 Bristol myers squibb pharma Description and Business Overview
11.1.3 Bristol myers squibb pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol myers squibb pharma Antithrombotic Drugs Products Offered
11.1.5 Bristol myers squibb pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antithrombotic Drugs Market Estimates and Projections by Region
12.1.1 Global Antithrombotic Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Antithrombotic Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Antithrombotic Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Antithrombotic Drugs Sales Forecast (2021-2026)
12.2.2 North America: Antithrombotic Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Antithrombotic Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Antithrombotic Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Antithrombotic Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Antithrombotic Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Antithrombotic Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antithrombotic Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antithrombotic Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antithrombotic Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antithrombotic Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Antithrombotic Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Antithrombotic Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Antithrombotic Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Antithrombotic Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antithrombotic Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antithrombotic Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antithrombotic Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antithrombotic Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antithrombotic Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antithrombotic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antithrombotic Drugs Market Segments
Table 2. Ranking of Global Top Antithrombotic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antithrombotic Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Apixaban
Table 5. Major Manufacturers of Debigatran
Table 6. Major Manufacturers of Edoxaban
Table 7. Major Manufacturers of Fondaparinux
Table 8. Major Manufacturers of Heparin
Table 9. Major Manufacturers of Rivaroxaban
Table 10. Global Antithrombotic Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Antithrombotic Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Antithrombotic Drugs Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Antithrombotic Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global Antithrombotic Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Antithrombotic Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Antithrombotic Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global Antithrombotic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Antithrombotic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antithrombotic Drugs as of 2019)
Table 19. Antithrombotic Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Antithrombotic Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Antithrombotic Drugs Price (2015-2020) (USD/Pcs)
Table 22. Antithrombotic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Antithrombotic Drugs Product Type
Table 24. Date of International Manufacturers Enter into Antithrombotic Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Antithrombotic Drugs Sales by Type (2015-2020) (K Pcs)
Table 27. Global Antithrombotic Drugs Sales Share by Type (2015-2020)
Table 28. Global Antithrombotic Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Antithrombotic Drugs Revenue Share by Type (2015-2020)
Table 30. Antithrombotic Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Antithrombotic Drugs Sales by Application (2015-2020) (K Pcs)
Table 32. Global Antithrombotic Drugs Sales Share by Application (2015-2020)
Table 33. North America Antithrombotic Drugs Sales by Country (2015-2020) (K Pcs)
Table 34. North America Antithrombotic Drugs Sales Market Share by Country (2015-2020)
Table 35. North America Antithrombotic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Antithrombotic Drugs Revenue Market Share by Country (2015-2020)
Table 37. North America Antithrombotic Drugs Sales by Type (2015-2020) (K Pcs)
Table 38. North America Antithrombotic Drugs Sales Market Share by Type (2015-2020)
Table 39. North America Antithrombotic Drugs Sales by Application (2015-2020) (K Pcs)
Table 40. North America Antithrombotic Drugs Sales Market Share by Application (2015-2020)
Table 41. Europe Antithrombotic Drugs Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Antithrombotic Drugs Sales Market Share by Country (2015-2020)
Table 43. Europe Antithrombotic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Antithrombotic Drugs Revenue Market Share by Country (2015-2020)
Table 45. Europe Antithrombotic Drugs Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Antithrombotic Drugs Sales Market Share by Type (2015-2020)
Table 47. Europe Antithrombotic Drugs Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Antithrombotic Drugs Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Antithrombotic Drugs Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Antithrombotic Drugs Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Antithrombotic Drugs Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Antithrombotic Drugs Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Antithrombotic Drugs Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Antithrombotic Drugs Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Antithrombotic Drugs Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Antithrombotic Drugs Sales Market Share by Application (2015-2020)
Table 57. Latin America Antithrombotic Drugs Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Antithrombotic Drugs Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Antithrombotic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Antithrombotic Drugs Revenue Market Share by Country (2015-2020)
Table 61. Latin America Antithrombotic Drugs Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Antithrombotic Drugs Sales Market Share by Type (2015-2020)
Table 63. Latin America Antithrombotic Drugs Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Antithrombotic Drugs Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Antithrombotic Drugs Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Antithrombotic Drugs Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Antithrombotic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Antithrombotic Drugs Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Antithrombotic Drugs Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Antithrombotic Drugs Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Antithrombotic Drugs Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Antithrombotic Drugs Sales Market Share by Application (2015-2020)
Table 73. Bristol myers squibb pharma Corporation Information
Table 74. Bristol myers squibb pharma Description and Major Businesses
Table 75. Bristol myers squibb pharma Antithrombotic Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Bristol myers squibb pharma Product
Table 77. Bristol myers squibb pharma Recent Development
Table 78. Abbott laboratories Corporation Information
Table 79. Abbott laboratories Description and Major Businesses
Table 80. Abbott laboratories Antithrombotic Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Abbott laboratories Product
Table 82. Abbott laboratories Recent Development
Table 83. Pliva Corporation Information
Table 84. Pliva Description and Major Businesses
Table 85. Pliva Antithrombotic Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Pliva Product
Table 87. Pliva Recent Development
Table 88. Sandoz Corporation Information
Table 89. Sandoz Description and Major Businesses
Table 90. Sandoz Antithrombotic Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Sandoz Product
Table 92. Sandoz Recent Development
Table 93. Pfizer Corporation Information
Table 94. Pfizer Description and Major Businesses
Table 95. Pfizer Antithrombotic Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Pfizer Product
Table 97. Pfizer Recent Development
Table 98. Pharmacia Corporation Information
Table 99. Pharmacia Description and Major Businesses
Table 100. Pharmacia Antithrombotic Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Pharmacia Product
Table 102. Pharmacia Recent Development
Table 103. Watson laboratories Corporation Information
Table 104. Watson laboratories Description and Major Businesses
Table 105. Watson laboratories Antithrombotic Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Watson laboratories Product
Table 107. Watson laboratories Recent Development
Table 108. Zydus pharmaceuticals usa Corporation Information
Table 109. Zydus pharmaceuticals usa Description and Major Businesses
Table 110. Zydus pharmaceuticals usa Antithrombotic Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Zydus pharmaceuticals usa Product
Table 112. Zydus pharmaceuticals usa Recent Development
Table 113. Bristol-Myers Squibb Corporation Information
Table 114. Bristol-Myers Squibb Description and Major Businesses
Table 115. Bristol-Myers Squibb Antithrombotic Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Bristol-Myers Squibb Product
Table 117. Bristol-Myers Squibb Recent Development
Table 118. Global Antithrombotic Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 119. Global Antithrombotic Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 120. Global Antithrombotic Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 121. Global Antithrombotic Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 122. North America: Antithrombotic Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. North America: Antithrombotic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Europe: Antithrombotic Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Europe: Antithrombotic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Asia Pacific: Antithrombotic Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 127. Asia Pacific: Antithrombotic Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 128. Latin America: Antithrombotic Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 129. Latin America: Antithrombotic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Middle East and Africa: Antithrombotic Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 131. Middle East and Africa: Antithrombotic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 133. Key Challenges
Table 134. Market Risks
Table 135. Main Points Interviewed from Key Antithrombotic Drugs Players
Table 136. Antithrombotic Drugs Customers List
Table 137. Antithrombotic Drugs Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Antithrombotic Drugs Product Picture
Figure 2. Global Antithrombotic Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Apixaban Product Picture
Figure 4. Debigatran Product Picture
Figure 5. Edoxaban Product Picture
Figure 6. Fondaparinux Product Picture
Figure 7. Heparin Product Picture
Figure 8. Rivaroxaban Product Picture
Figure 9. Global Antithrombotic Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. General Pharmacies
Figure 11. Hospital Pharmacies
Figure 12. Online Retailers
Figure 13. Drug Stores
Figure 14. Antithrombotic Drugs Report Years Considered
Figure 15. Global Antithrombotic Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global Antithrombotic Drugs Sales 2015-2026 (K Pcs)
Figure 17. Global Antithrombotic Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Antithrombotic Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Antithrombotic Drugs Sales Market Share by Region in 2019
Figure 20. Global Antithrombotic Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Antithrombotic Drugs Revenue Market Share by Region in 2019
Figure 22. Global Antithrombotic Drugs Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Antithrombotic Drugs Revenue in 2019
Figure 24. Antithrombotic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Antithrombotic Drugs Sales Market Share by Type (2015-2020)
Figure 26. Global Antithrombotic Drugs Sales Market Share by Type in 2019
Figure 27. Global Antithrombotic Drugs Revenue Market Share by Type (2015-2020)
Figure 28. Global Antithrombotic Drugs Revenue Market Share by Type in 2019
Figure 29. Global Antithrombotic Drugs Market Share by Price Range (2015-2020)
Figure 30. Global Antithrombotic Drugs Sales Market Share by Application (2015-2020)
Figure 31. Global Antithrombotic Drugs Sales Market Share by Application in 2019
Figure 32. Global Antithrombotic Drugs Revenue Market Share by Application (2015-2020)
Figure 33. Global Antithrombotic Drugs Revenue Market Share by Application in 2019
Figure 34. North America Antithrombotic Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Antithrombotic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Antithrombotic Drugs Sales Market Share by Country in 2019
Figure 37. North America Antithrombotic Drugs Revenue Market Share by Country in 2019
Figure 38. U.S. Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Antithrombotic Drugs Market Share by Type in 2019
Figure 43. North America Antithrombotic Drugs Market Share by Application in 2019
Figure 44. Europe Antithrombotic Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Antithrombotic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Antithrombotic Drugs Sales Market Share by Country in 2019
Figure 47. Europe Antithrombotic Drugs Revenue Market Share by Country in 2019
Figure 48. Germany Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Antithrombotic Drugs Market Share by Type in 2019
Figure 59. Europe Antithrombotic Drugs Market Share by Application in 2019
Figure 60. Asia Pacific Antithrombotic Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Antithrombotic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Antithrombotic Drugs Sales Market Share by Region in 2019
Figure 63. Asia Pacific Antithrombotic Drugs Revenue Market Share by Region in 2019
Figure 64. China Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Antithrombotic Drugs Market Share by Type in 2019
Figure 87. Asia Pacific Antithrombotic Drugs Market Share by Application in 2019
Figure 88. Latin America Antithrombotic Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Antithrombotic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Antithrombotic Drugs Sales Market Share by Country in 2019
Figure 91. Latin America Antithrombotic Drugs Revenue Market Share by Country in 2019
Figure 92. Mexico Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Antithrombotic Drugs Market Share by Type in 2019
Figure 99. Latin America Antithrombotic Drugs Market Share by Application in 2019
Figure 100. Middle East and Africa Antithrombotic Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Antithrombotic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Antithrombotic Drugs Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Antithrombotic Drugs Revenue Market Share by Country in 2019
Figure 104. Turkey Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Antithrombotic Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Antithrombotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Antithrombotic Drugs Market Share by Type in 2019
Figure 111. Middle East and Africa Antithrombotic Drugs Market Share by Application in 2019
Figure 112. North America Antithrombotic Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Antithrombotic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Antithrombotic Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Antithrombotic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Antithrombotic Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Antithrombotic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Antithrombotic Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Antithrombotic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Antithrombotic Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Antithrombotic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…- 植物・植物由来薬剤の世界市場（～2026年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…
- OTC外用薬の世界市場（～2026年） Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…
- 神経因性疼痛治療薬の世界市場（～2026年） Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of value, North America is a large market and is expected to…
- 眼科用治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Ophthalmic Therapeutic Drugs Scope and Market Size…